AstraZeneca to Expand UK R&D Following US-UK Trade Agreement

AstraZeneca is set to expand its research and development operations in the UK, benefiting from provisions in the latest US-UK trade agreement that aim to boost UK drug spending. This move underscores the positive impact of international trade deals on pharmaceutical investment and innovation in the region.